Eric Schwartz
Insider (Form 4 reporting owner): EVP, Chief Legal Officer & Sec CIK 1329100Name as filed: Schwartz EricIts filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 28 Mar 2018, sold $2.5M in 6 sales and bought $100K in 1 open-market purchase across 2 companies.
Companies
Role on the latest Form 4 for each; open-market trades counted| Company | Role | Trades from | to | Purchases | Sales |
|---|---|---|---|---|---|
| Globus Medical GMED | Senior VP and General Counsel | 28 Mar 2018 | 25 Jun 2018 | – | 2$1.7M |
| Integra LifeSciences IART | EVP, Chief Legal Officer & Sec | 5 Dec 2019 | 3 Dec 2024 | 1$100K | 4$797K |
What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After purchases | too few trades1 trade | too few trades1 trade | too few trades1 trade |
| After sales | +0.5 pts5 trades, 80% above the sector | -8.8 pts5 trades, 0.00% above the sector | -22.6 pts5 trades, 40% above the sector |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2024 | – | – | 1 | $100K | -$100K |
| 2023 | 1 | $100K | – | – | $100K |
| 2021 | – | – | 2 | $450K | -$450K |
| 2019 | – | – | 1 | $247K | -$247K |
| 2018 | – | – | 2 | $1.7M | -$1.7M |
Every trade
7, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 3 Dec 2024 | Integra LifeSciences IART | Sell | 4,070 | $24.60 | $100K | No | Form 4filed 4 Dec 2024 |
| 1 Jun 2023 | Integra LifeSciences IART | Buy | 2,640 | $37.89 | $100K | No | Form 4filed 5 Jun 2023 |
| 2 Mar 2021 | Integra LifeSciences IART | Sell | 4,212 | $69.10 | $291K | Not stated | Form 4filed 3 Mar 2021 |
| 25 Feb 2021 | Integra LifeSciences IART | Sell | 2,288 | $69.52 | $159K | Not stated | Form 4filed 1 Mar 2021 |
| 5 Dec 2019 | Integra LifeSciences IART | Sell | 4,007 | $61.62 | $247K | Not stated | Form 4filed 5 Dec 2019 |
| 25 Jun 2018 | Globus Medical GMED | Sellafter exercising options | 10,000 | $53.79 | $538K | Not stated | Form 4filed 27 Jun 2018 |
| 28 Mar 2018 | Globus Medical GMED | Sellafter exercising options | 24,000 | $50.00 | $1.2M | Not stated | Form 4filed 30 Mar 2018 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.